(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

USO DE TRABEDERSEN E IL-2

ConcedidaInvention PatentPCT · KR2019012178

Application data

Number

112021005012

Type

Invention Patent

Filing

09/19/2019

Publication

06/08/2021

PCT

KR2019012178

Progress at the INPI

  1. Filing09/19/19
  2. Publication06/08/21
  3. Examination
  4. Allowance02/11/25
  5. Grant04/01/25
  6. In force09/19/39

The patent was granted on 04/01/2025 and is in force until 09/19/2039. Until then, no one may make, use or sell the invention in Brazil without the owner's authorisation.

Protection valid until:09/19/2039

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 04/01/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

AUTOTELIC BIO INC.

KR

Inventors

J. L. (pessoa física)

KR

J. P. (pessoa física)

KR

T. K. (pessoa física)

KR

Technical data

Priority claims

KR

10-2018-0112506 · 09/19/2018

Abstract

COMPOSIÇÃO ANTICÂNCER E USO DE TRABEDERSEN E IL-2.É divulgada uma composição de fórmula anticâncer compreendendo trabedersen e IL-2.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Concessão da patente

#16.1

Prazo de Validade: 20 (vinte) anos contados a partir de 19/09/2019, observadas as condições legais

04/01/2025

RPI 2830

Deferimento

#9.1

02/11/2025

RPI 2823

Conhecimento de parecer técnico

#7.1

10/29/2024

RPI 2808

Parecer de pré-exame

#6.23

07/09/2024

RPI 2792

Notificação de entrada na fase nacional - PCT

#1.3

06/08/2021

RPI 2631

Alteração de dados cadastrais

#1.1

03/30/2021

RPI 2621

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.